• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The Authors' Reply to "Revascularization in Peritoneal Dialysis: Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting".作者对《腹膜透析中的血运重建：经皮冠状动脉介入治疗与冠状动脉旁路移植术》的回复
Kidney Med. 2024 Aug 8;6(9):100885. doi: 10.1016/j.xkme.2024.100885. eCollection 2024 Sep.
2
Percutaneous Coronary Intervention With a Drug-Eluting Stent Versus Coronary Artery Bypass Grafting in Patients Receiving Dialysis: A National Study From Taiwan.接受透析治疗患者的药物洗脱支架经皮冠状动脉介入治疗与冠状动脉旁路移植术：一项来自台湾的全国性研究
Kidney Med. 2023 Dec 5;6(2):100768. doi: 10.1016/j.xkme.2023.100768. eCollection 2024 Feb.
3
Choice of revascularization strategy for ischemic cardiomyopathy due to multivessel coronary disease.多支冠状动脉疾病所致缺血性心肌病的血运重建策略选择
J Thorac Cardiovasc Surg. 2025 Feb;169(2):639-647.e21. doi: 10.1016/j.jtcvs.2024.03.007. Epub 2024 Mar 15.
4
Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States.美国经皮冠状动脉血运重建术和药物洗脱支架与裸金属支架治疗后透析患者的长期生存和重复冠状动脉血运重建
Circulation. 2013 May 7;127(18):1861-9. doi: 10.1161/CIRCULATIONAHA.112.001264. Epub 2013 Apr 9.
5
Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with second-generation drug-eluting stents for patients with multivessel and unprotected left main coronary artery disease.多支血管病变及无保护左主干冠状动脉疾病患者冠状动脉旁路移植术与第二代药物洗脱支架经皮冠状动脉介入治疗的结果
SAGE Open Med. 2017 Jan 18;5:2050312116687707. doi: 10.1177/2050312116687707. eCollection 2017.
6
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.冠状动脉血运重建术后卒率比较：外科手术与经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.
7
The effect of treatment timing on repeat revascularization in patients with stable ischemic heart disease.治疗时机对稳定型缺血性心脏病患者重复血运重建的影响。
JTCVS Open. 2024 Apr 22;19:164-174. doi: 10.1016/j.xjon.2024.04.009. eCollection 2024 Jun.
8
Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase.当前针对三支血管病变及左主干冠状动脉疾病的经皮冠状动脉介入治疗和冠状动脉旁路移植术实践。来自SYNTAX导入期的见解。
Eur J Cardiothorac Surg. 2006 Apr;29(4):486-91. doi: 10.1016/j.ejcts.2006.01.047. Epub 2006 Feb 23.
9
Percutaneous coronary intervention versus repeat surgical revascularization in patients with prior coronary artery bypass grafting: A systematic review and meta-analysis.既往接受冠状动脉旁路移植术患者的经皮冠状动脉介入治疗与再次外科血运重建：一项系统评价和荟萃分析。
JTCVS Open. 2022 Oct 28;12:177-191. doi: 10.1016/j.xjon.2022.10.006. eCollection 2022 Dec.
10
Procedure rates and outcomes of coronary revascularization procedures in California and New York.加利福尼亚州和纽约州冠状动脉血运重建手术的手术率及结果。
J Thorac Cardiovasc Surg. 2005 Jun;129(6):1276-82. doi: 10.1016/j.jtcvs.2004.12.043.

本文引用的文献

1
Unveiling Nuances in Revascularization: A Call for Focused Exploration in Peritoneal Dialysis Patients.揭示血管再通的细微差别：呼吁对腹膜透析患者进行重点探索。
Kidney Med. 2024 Jul 14;6(9):100870. doi: 10.1016/j.xkme.2024.100870. eCollection 2024 Sep.
2
Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients Receiving Dialysis: Is CABG Worth the Risk?接受透析治疗的患者冠状动脉旁路移植术与经皮冠状动脉介入治疗的比较：冠状动脉旁路移植术值得冒风险吗？
Kidney Med. 2023 Dec 22;6(2):100787. doi: 10.1016/j.xkme.2023.100787. eCollection 2024 Feb.
3
Percutaneous Coronary Intervention With a Drug-Eluting Stent Versus Coronary Artery Bypass Grafting in Patients Receiving Dialysis: A National Study From Taiwan.接受透析治疗患者的药物洗脱支架经皮冠状动脉介入治疗与冠状动脉旁路移植术：一项来自台湾的全国性研究
Kidney Med. 2023 Dec 5;6(2):100768. doi: 10.1016/j.xkme.2023.100768. eCollection 2024 Feb.

The Authors' Reply to "Revascularization in Peritoneal Dialysis: Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting".

作者信息

Pan Szu-Yu, Teng Nai-Chi, Chen Likwang

机构信息

Department of Integrated Diagnostics and Therapeutics, National Taiwan University Hospital, Taipei, Taiwan.

Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Kidney Med. 2024 Aug 8;6(9):100885. doi: 10.1016/j.xkme.2024.100885. eCollection 2024 Sep.

DOI:10.1016/j.xkme.2024.100885
PMID:39263214
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11387245/
Abstract
摘要